Harten Group Seeks More Consultants
To Meet Growing Demand
The Harten Group, Europe’s leading interim management specialist, based near Cambridge is looking for further consultants to join its network, following a growing demand for its services from global pharmaceutical and biotechnology companies.
Celebrating its tenth anniversary year, The Group provides specialist interim managers to fulfil a particular project or fill a gap in staffing resource.
The Company has also just broken a record in finding a leading role for one of its consultants in just three days.
Dr. Bryan Shapiro, who has recently returned to the UK from Australia, was looking for a senior interim medical affairs role and contacted the Group.
He says: “I was impressed by the speed with which everything was completed. Within just hours of having a telephone interview, all the wheels were in motion and arrangements made for me to start in my new position”.
The Harten Group, which has a network of over 1000 consultants, is always keen to hear from other consultants seeking interim assignments in the life sciences sector. In addition to medical affairs, other roles supported by The Group include clinical research, business development and senior executive positions including CEOs.
In addition to interim management, Harten Group services include technical consulting, project management, permanent recruitment and strategic planning. Recent clients include: AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme, Wyeth, Powderject, 3i, Cambridge Gateway Fund, Johnson & Johnson, Adprotech and Cambridge Biotechnology.
Further information about The Harten Group can be found on www.hartengroup.co.uk which contains an innovative search capability enabling clients to look for potential executive interim managers within the company’s network of 1000 consultants. This feature is unique among life science industry providers and is routinely used by clients to identify matches with their skills needs.
For more information:
Last updated on: 27/08/2010